These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7903297

  • 1. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.
    Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y.
    J Biochem; 1993 Aug; 114(2):263-6. PubMed ID: 7903297
    [Abstract] [Full Text] [Related]

  • 2. Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease.
    Tsuneoka Y, Matsuo Y, Ichikawa Y, Watanabe Y.
    Metabolism; 1998 Jan; 47(1):94-6. PubMed ID: 9440484
    [Abstract] [Full Text] [Related]

  • 3. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R, Broly F, Destée A, Libersa C.
    Adv Neurol; 1996 Jan; 69():97-100. PubMed ID: 8615190
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CYP2D6 genotype determination in the Danish population.
    Brøsen K, Nielsen PN, Brusgaard K, Gram LF, Skjødt K.
    Eur J Clin Pharmacol; 1994 Jan; 47(3):221-5. PubMed ID: 7867674
    [Abstract] [Full Text] [Related]

  • 8. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
    Landi MT, Ceroni M, Martignoni E, Bertazzi PA, Caporaso NE, Nappi G.
    Adv Neurol; 1996 Jan; 69():61-72. PubMed ID: 8615186
    [No Abstract] [Full Text] [Related]

  • 9. Mutant debrisoquine hydroxylation genes in Parkinson's disease.
    Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR.
    Lancet; 1992 Apr 25; 339(8800):1017-8. PubMed ID: 1349052
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
    Planté-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE.
    J Neurol Neurosurg Psychiatry; 1994 Aug 25; 57(8):911-3. PubMed ID: 8057112
    [Abstract] [Full Text] [Related]

  • 13. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.
    Broly F, Meyer UA.
    Pharmacogenetics; 1993 Jun 25; 3(3):123-30. PubMed ID: 8101460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy.
    Iwahashi K, Miyatake R, Tsuneoka Y, Matsuo Y, Ichikawa Y, Hosokawa K, Sato K, Hayabara T.
    J Neurol Neurosurg Psychiatry; 1995 Feb 25; 58(2):263-4. PubMed ID: 7876880
    [No Abstract] [Full Text] [Related]

  • 17. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Panserat S, Mura C, Gérard N, Vincent-Viry M, Galteau MM, Jacqz-Aigrain E, Krishnamoorthy R.
    Hum Genet; 1994 Oct 25; 94(4):401-6. PubMed ID: 7927337
    [Abstract] [Full Text] [Related]

  • 18. Debrisoquine hydroxylase and Parkinson's disease.
    Kondo I, Kanazawa I.
    Adv Neurol; 1993 Oct 25; 60():338-42. PubMed ID: 8420147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.